Vice President of Commercial Strategy jobs in United States
cer-icon
Apply on Employer Site
company-logo

Neurona Therapeutics · 1 month ago

Vice President of Commercial Strategy

positionSouth San Francisco, CA
timeFull-time
remoteHybrid
seniorityDirector/Executive
money$285K/yr - $330K/yr
date15+ years exp

Neurona Therapeutics is a clinical-stage biotechnology company focused on developing allogeneic cell-based therapies for neurological diseases. They are seeking a Vice President of Commercial Strategy to lead the planning and execution of commercial readiness activities for their lead asset, ensuring a successful launch in a complex therapeutic space.

BiotechnologyHealth CareNeuroscienceTherapeutics

Responsibilities

Lead and own the commercial strategy and launch planning for Neurona’s lead clinical-stage program, ensuring a fully integrated cross-functional launch plan
Develop early brand strategy including positioning, segmentation, patient journey mapping, KOL engagement, and messaging in coordination with key stakeholders
Establish and lead the commercial launch team in collaboration with other functions (e.g., medical affairs, market access, CMC, regulatory, clinical)
Work closely with the executive team to define go-to-market models and long-term commercial infrastructure planning
Build early customer insights capabilities, including market research, advisory boards, and engagement strategy
Identify and prioritize key market development activities to shape the external environment for launch readiness
Drive strategic pricing & access strategy and commercialization scenarios
Engage with potential partners or collaborators on commercial-related matters when needed
Lead commercial input into lifecycle management and pipeline development strategies
Provide commercial leadership in partnerships, fundraising, and strategic collaborations
Represent the commercial voice in executive meetings, board updates, and external presentations

Qualification

Biotech commercializationProduct launch strategyNeurology expertiseMarket developmentCross-functional collaborationLeadership skillsCommunication skillsOrganizational skillsStrategic thinking

Required

Lead and own the commercial strategy and launch planning for Neurona's lead clinical-stage program, ensuring a fully integrated cross-functional launch plan
Develop early brand strategy including positioning, segmentation, patient journey mapping, KOL engagement, and messaging in coordination with key stakeholders
Establish and lead the commercial launch team in collaboration with other functions (e.g., medical affairs, market access, CMC, regulatory, clinical)
Work closely with the executive team to define go-to-market models and long-term commercial infrastructure planning
Build early customer insights capabilities, including market research, advisory boards, and engagement strategy
Identify and prioritize key market development activities to shape the external environment for launch readiness
Drive strategic pricing & access strategy and commercialization scenarios
Engage with potential partners or collaborators on commercial-related matters when needed
Lead commercial input into lifecycle management and pipeline development strategies
Provide commercial leadership in partnerships, fundraising, and strategic collaborations
Represent the commercial voice in executive meetings, board updates, and external presentations

Preferred

15+ years of progressive experience in biotech/pharma with a strong background in product launch strategy, particularly in neurology, cell therapy, rare disease, or adjacent therapeutic areas
Experience leading commercial planning prior to product approval, especially in emerging or first-in-class technologies
Proven track record of launching innovative therapeutics, ideally in neurology, rare diseases, or cell/gene therapy
Strong strategic thinker who can operate effectively in an early-stage, fast-paced environment and is comfortable with ambiguity
Experience working cross-functionally with R&D, medical, market access, regulatory, and CMC teams
Demonstrated ability to build commercial capabilities from the ground up
Excellent leadership, communication, and organizational skills
Advanced degree (MBA, PhD, or equivalent) preferred

Company

Neurona Therapeutics

twittertwitter
company-logo
Neurona Therapeutics develops cell therapies for neurological disorders, focusing on treatments like NRTX-1001 for epilepsy.
dateFounded in 2008
location
South San Francisco, California, USA
people-size51-200 employees
web-link
http://www.neuronatherapeutics.com

Funding

Current Stage
Late Stage
Total Funding
$440.11M
Key Investors
California Institute for Regenerative MedicineSouth Carolina Research AuthorityNational Institutes of Health
2025-06-18Grant· $14M
2025-04-03Series F· $102M
2024-09-10Grant· $3.8M

Leadership Team

leader-logo
James Stutz
Chief Financial Officer / Chief Business Officer
linkedin
leader-logo
Nadia Agopyan
Senior Vice President
linkedin

Recent News

GlobeNewswire
Neurona Therapeutics Presents New Long-Term Clinical Data from NRTX-1001 Cell Therapy Trials at 2025 Annual Meeting of the American Epilepsy Society
2025-12-08
Neurona Therapeutics
Neurona Therapeutics Appoints Dr. Eduardo Dunayevich as Chief Medical Officer
2025-11-19
Longevity.Technology - Latest News, Opinions, Analysis and Research
Neurona Therapeutics receives EMA PRIME designation for NRTX-1001 in drug-resistant focal epilepsy
2025-11-08
Company data provided by crunchbase